Answers are grounded in this paper and cite their sources.
Background Bullous pemphigoid (BP) is the most common autoimmune blistering skin disease, primarily affecting the elderly. The role of interleukin‐13 (IL‐13) in BP pathogenesis remains unclear, particularly regarding its potential as a therapeutic target. Objectives To evaluate differences in serum IL‐13 levels between idiopathic and drug‐induced BP patients and healthy controls, and to investigate correlations between IL‐13 levels, disease severity, mucosal involvement, and prognosis. Methods This retrospective cohort study included 42 BP patients diagnosed between 2008 and 2023 at a dermatology referral center, along with 12 healthy controls and four pemphigus vulgaris patients. Serum IL‐13 levels were measured using ELISA. The primary outcomes were IL‐13 levels and their association with disease etiology, eosinophil counts, mucosal involvement, and the need for adjuvant therapy. Results Serum IL‐13 levels were lower in BP patients ( n = 42, mean 62.46 pg/mL ± 16.53) compared to healthy controls ( n = 12, mean 87.83 pg/mL ±8.87, p < 0.0001) and pemphigus patients ( n = 4, mean 87.6 pg/mL ± 5.16, p = 0.013). Idiopathic BP patients exhibited higher IL‐13 levels than Dipeptidyl peptidase‐4 (DPP4) ‐induced BP patients (67.01 pg/mL ± 14.3 vs. 57.36 pg/mL ± 21, p = 0.0104). No significant correlation was found between IL‐13 levels and mucosal involvement ( p = 0.338), eosinophil counts (Pearson correlation coefficient = 0.18, p = 0.253), the need for adjuvant therapy ( p = 0.32), or prognosis ( p = 0.45). Higher eosinophil levels correlated with the need for adjuvant therapy ( p = 0.027). Conclusions Serum IL‐13 levels are lower in BP patients compared to healthy controls, and in DPP4‐induced BP compared to idiopathic BP, suggesting a complex role of IL‐13 in BP pathogenesis. IL‐13 levels did not correlate with disease severity or prognosis, indicating that IL‐13 may not be a reliable marker for BP severity or outcome. Further research is needed to clarify IL‐13's role in BP and to guide therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Dawood et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: